login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
ANIXA BIOSCIENCES INC (ANIX) Stock News
USA
- NASDAQ:ANIX -
US03528H1095
-
Common Stock
4.34
USD
-0.06 (-1.36%)
Last: 11/21/2025, 4:00:42 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ANIX Latest News, Press Relases and Analysis
All
Press Releases
4 days ago - By: Anixa Biosciences, Inc.
Anixa Biosciences Announces World Health Organization (WHO) Approval of International Non-Proprietary Name for its CAR-T Therapy, Marking a Key Milestone Toward Global Recognition and Future Commercialization
11 days ago - By: Anixa Biosciences, Inc.
Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Tuesday, November 11, 2025
16 days ago - By: Zacks Investment Research
- Mentions:
BSX
Is Anixa Biosciences (ANIX) Stock Outpacing Its Medical Peers This Year?
16 days ago - By: Anixa Biosciences, Inc.
Anixa Biosciences Announces Execution of Data Transfer Agreement with Cleveland Clinic
a month ago - By: Anixa Biosciences, Inc.
Anixa Biosciences to Present at the Spartan Capital Securities Second Annual Investor Conference
a month ago - By: Anixa Biosciences, Inc.
Anixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology
a month ago - By: Zacks Investment Research
Are You Looking for a Top Momentum Pick? Why ANIXA BIOSCIENCES INC (ANIX) is a Great Choice
2 months ago - By: Zacks Investment Research
- Mentions:
AMRX
Are Medical Stocks Lagging Amneal Pharmaceuticals (AMRX) This Year?
2 months ago - By: Anixa Biosciences, Inc.
Cleveland Clinic to Present Final Results of Phase 1 Clinical Trial for Anixa Biosciences' Breast Cancer Vaccine at 2025 San Antonio Breast Cancer Symposium
2 months ago - By: Anixa Biosciences, Inc.
Anixa Biosciences and Moffitt Cancer Center Complete Dosing of Fourth Cohort in Ovarian Cancer CAR-T Clinical Trial; Multiple Patients Surpassing Median Expected Survival
3 months ago - By: Anixa Biosciences, Inc.
Anixa Biosciences Announces Time Change for Presentation at the H.C. Wainwright 27th Annual Global Investment Conference
3 months ago - By: Anixa Biosciences, Inc.
Anixa Biosciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference
3 months ago - By: Anixa Biosciences, Inc.
Anixa Biosciences Receives Notice of Allowance from Chinese National Intellectual Property Administration for Patent Covering Breast Cancer Vaccine Technology
3 months ago - By: Anixa Biosciences, Inc.
Anixa Biosciences Announces Treatment of Second Patient in Fourth Cohort of Ovarian Cancer CAR-T Clinical Trial
3 months ago - By: Anixa Biosciences, Inc.
Anixa Biosciences Announces Issuance of Additional U.S. Patent for CAR-T Technology
4 months ago - By: Anixa Biosciences, Inc.
Anixa Biosciences Announces Dr. Robert Wenham will speak about Immunotherapy in surviving Ovarian Cancer at the 13th Annual Ovarcoming Cancer Conference
4 months ago - By: Anixa Biosciences, Inc.
Anixa Biosciences Announces Commencement of US FDA Approved IND Transfer to Support Upcoming Phase 2 Breast Cancer Vaccine Trial
5 months ago - By: Anixa Biosciences, Inc.
Anixa Biosciences to Host an Investor Webcast on June 26, 2025
5 months ago - By: Anixa Biosciences, Inc.
Anixa Biosciences' Breast Cancer Vaccine Receives National News Coverage
6 months ago - By: Zacks Investment Research
All You Need to Know About Anixa Biosciences (ANIX) Rating Upgrade to Buy
6 months ago - By: Zacks Investment Research
- Mentions:
CLRB
Are Medical Stocks Lagging Anixa Biosciences (ANIX) This Year?
6 months ago - By: Anixa Biosciences, Inc.
Anixa Biosciences' Breast Cancer Vaccine Featured in NewsNation Interview
6 months ago - By: Anixa Biosciences, Inc.
Anixa Biosciences Announces Completion of Enrollment in Phase 1 Trial of Breast Cancer Vaccine
6 months ago - By: Anixa Biosciences, Inc.
Anixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
7 months ago - By: Anixa Biosciences, Inc.
Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio
8 months ago - By: Anixa Biosciences, Inc.
Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology
8 months ago - By: Benzinga
EXCLUSIVE: Anixa Biosciences Receives Key US Patent Nod For Breast Cancer Vaccine Patent
8 months ago - By: Yahoo Finance
EXCLUSIVE: Anixa Biosciences Receives Key US Patent Nod For Breast Cancer Vaccine Patent
8 months ago - By: Benzinga
- Mentions:
PTIX
AEMD
SLRX
WORX
...
12 Health Care Stocks Moving In Tuesday's After-Market Session
8 months ago - By: Anixa Biosciences, Inc.
Anixa Biosciences to Present at the Jones Las Vegas Healthcare and Technology Innovation Conference on April 9th
8 months ago - By: Anixa Biosciences, Inc.
Anixa Biosciences Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer Vaccines
Please enable JavaScript to continue using this application.